世界のテモゾロミド市場 2019年

【英語タイトル】Global Temozolomide Market Professional Survey Report 2019

QYResearchが出版した調査資料(DATA909X16318)・商品コード:DATA909X16318
・発行会社(調査会社):QYResearch
・発行日:2019年11月22日(※2024年版があります。お問い合わせください)
・ページ数:108
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医薬品・ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥518,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,250 ⇒換算¥777,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,000 ⇒換算¥1,036,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※本調査レポートは、テモゾロミドの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、カプセル、注射剤に、用途別には、病院、クリニックにセグメント区分し、テモゾロミドの世界市場を分析しました。


・エグゼクティブ・サマリー
・テモゾロミドの世界市場概要
・テモゾロミドの製造コスト構成分析
・テモゾロミドの開発・製造工場分析
・主要メーカーの主な指標(生産能力、売上、価格分析)
・テモゾロミドの地域別分析(生産、売上、主要メーカー、輸出・輸入)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・テモゾロミドのセグメント分析(種類別)
(カプセル、注射剤)
・テモゾロミドのセグメント分析(用途別)
(病院、クリニック)
・テモゾロミドの主要メーカー別分析(生産拠点、製品概要、生産・売上実績)
(Merck、SL Pharme、Sun Pharma、Mayne Pharma、Schering-Plough、Cipla、)
・テモゾロミドの市場規模予測(2019年~2025年)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス(市場動向、機会、成長要因、課題、影響因子)
...
【レポートの概要】

The global Temozolomide market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Temozolomide volume and value at global level, regional level and company level. From a global perspective, this report represents overall Temozolomide market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Temozolomide in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Temozolomide manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Merck
SL Pharme
Sun Pharma
Mayne Pharma
Schering-Plough
Cipla

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Capsules
Injection

Segment by Application
Hospital
Clinic

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Temozolomide
1.1 Definition of Temozolomide
1.2 Temozolomide Segment by Type
1.2.1 Global Temozolomide Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Capsules
1.2.3 Injection
1.3 Temozolomide Segment by Applications
1.3.1 Global Temozolomide Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Temozolomide Overall Market
1.4.1 Global Temozolomide Revenue (2014-2025)
1.4.2 Global Temozolomide Production (2014-2025)
1.4.3 North America Temozolomide Status and Prospect (2014-2025)
1.4.4 Europe Temozolomide Status and Prospect (2014-2025)
1.4.5 China Temozolomide Status and Prospect (2014-2025)
1.4.6 Japan Temozolomide Status and Prospect (2014-2025)
1.4.7 Southeast Asia Temozolomide Status and Prospect (2014-2025)
1.4.8 India Temozolomide Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Temozolomide
2.3 Manufacturing Process Analysis of Temozolomide
2.4 Industry Chain Structure of Temozolomide

3 Development and Manufacturing Plants Analysis of Temozolomide
3.1 Capacity and Commercial Production Date
3.2 Global Temozolomide Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Temozolomide
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Temozolomide Production and Capacity Analysis
4.2 Temozolomide Revenue Analysis
4.3 Temozolomide Price Analysis
4.4 Market Concentration Degree

5 Temozolomide Regional Market Analysis
5.1 Temozolomide Production by Regions
5.1.1 Global Temozolomide Production by Regions
5.1.2 Global Temozolomide Revenue by Regions
5.2 Temozolomide Consumption by Regions
5.3 North America Temozolomide Market Analysis
5.3.1 North America Temozolomide Production
5.3.2 North America Temozolomide Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Temozolomide Import and Export
5.4 Europe Temozolomide Market Analysis
5.4.1 Europe Temozolomide Production
5.4.2 Europe Temozolomide Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Temozolomide Import and Export
5.5 China Temozolomide Market Analysis
5.5.1 China Temozolomide Production
5.5.2 China Temozolomide Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Temozolomide Import and Export
5.6 Japan Temozolomide Market Analysis
5.6.1 Japan Temozolomide Production
5.6.2 Japan Temozolomide Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Temozolomide Import and Export
5.7 Southeast Asia Temozolomide Market Analysis
5.7.1 Southeast Asia Temozolomide Production
5.7.2 Southeast Asia Temozolomide Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Temozolomide Import and Export
5.8 India Temozolomide Market Analysis
5.8.1 India Temozolomide Production
5.8.2 India Temozolomide Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Temozolomide Import and Export

6 Temozolomide Segment Market Analysis (by Type)
6.1 Global Temozolomide Production by Type
6.2 Global Temozolomide Revenue by Type
6.3 Temozolomide Price by Type

7 Temozolomide Segment Market Analysis (by Application)
7.1 Global Temozolomide Consumption by Application
7.2 Global Temozolomide Consumption Market Share by Application (2014-2019)

8 Temozolomide Major Manufacturers Analysis
8.1 Merck
8.1.1 Merck Temozolomide Production Sites and Area Served
8.1.2 Merck Product Introduction, Application and Specification
8.1.3 Merck Temozolomide Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 SL Pharme
8.2.1 SL Pharme Temozolomide Production Sites and Area Served
8.2.2 SL Pharme Product Introduction, Application and Specification
8.2.3 SL Pharme Temozolomide Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Sun Pharma
8.3.1 Sun Pharma Temozolomide Production Sites and Area Served
8.3.2 Sun Pharma Product Introduction, Application and Specification
8.3.3 Sun Pharma Temozolomide Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Mayne Pharma
8.4.1 Mayne Pharma Temozolomide Production Sites and Area Served
8.4.2 Mayne Pharma Product Introduction, Application and Specification
8.4.3 Mayne Pharma Temozolomide Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Schering-Plough
8.5.1 Schering-Plough Temozolomide Production Sites and Area Served
8.5.2 Schering-Plough Product Introduction, Application and Specification
8.5.3 Schering-Plough Temozolomide Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Cipla
8.6.1 Cipla Temozolomide Production Sites and Area Served
8.6.2 Cipla Product Introduction, Application and Specification
8.6.3 Cipla Temozolomide Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served

9 Development Trend of Analysis of Temozolomide Market
9.1 Global Temozolomide Market Trend Analysis
9.1.1 Global Temozolomide Market Size (Volume and Value) Forecast 2019-2025
9.2 Temozolomide Regional Market Trend
9.2.1 North America Temozolomide Forecast 2019-2025
9.2.2 Europe Temozolomide Forecast 2019-2025
9.2.3 China Temozolomide Forecast 2019-2025
9.2.4 Japan Temozolomide Forecast 2019-2025
9.2.5 Southeast Asia Temozolomide Forecast 2019-2025
9.2.6 India Temozolomide Forecast 2019-2025
9.3 Temozolomide Market Trend (Product Type)
9.4 Temozolomide Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Temozolomide Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Temozolomide
Table Global Temozolomide Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Temozolomide Production Market Share by Types in 2018
Figure Capsules Product Picture
Figure Injection Product Picture
Table Global Temozolomide Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Temozolomide Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinic
Figure Global Temozolomide Revenue (Million USD) (2014-2025)
Figure Global Temozolomide Production (K Units) (2014-2025)
Figure North America Temozolomide Market Size (Million USD) (2014-2025)
Figure Europe Temozolomide Market Size (Million USD) (2014-2025)
Figure China Temozolomide Market Size (Million USD) (2014-2025)
Figure Japan Temozolomide Market Size (Million USD) (2014-2025)
Figure Southeast Asia Temozolomide Market Size (Million USD) (2014-2025)
Figure India Temozolomide Market Size (Million USD) (2014-2025)
Table Temozolomide Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Temozolomide in 2018
Figure Manufacturing Process Analysis of Temozolomide
Figure Industry Chain Structure of Temozolomide
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Temozolomide Manufacturing Plants Distribution
Table Temozolomide Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Temozolomide Capacity (K Units) of Major Manufacturers (2014-2019)
Table Temozolomide Production (K Units) of Major Manufacturers (2014-2019)
Table Temozolomide Production Market Share of Major Manufacturers (2014-2019)
Figure Temozolomide Production Share by Manufacturers in 2018
Table Temozolomide Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Temozolomide Revenue Market Share of Major Manufacturers (2014-2019)
Figure Temozolomide Revenue Share by Manufacturers in 2018
Table Temozolomide Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Temozolomide Production by Regions 2014-2019 (K Units)
Table Global Temozolomide Production Market Share by Regions 2014-2019
Figure Global Temozolomide Production Market Share by Regions in 2018
Table Global Temozolomide Revenue by Regions 2014-2019 (Million USD)
Table Global Temozolomide Revenue Market Share by Regions 2014-2019
Figure Global Temozolomide Revenue Market Share by Regions in 2018
Table Global Temozolomide Consumption by Regions 2014-2019 (K Units)
Table Global Temozolomide Consumption Market Share by Regions 2014-2019
Figure North America Temozolomide Production Growth Rate 2014-2019 (K Units)
Figure North America Temozolomide Revenue Growth Rate 2014-2019 (Million USD)
Table North America Temozolomide Production, Consumption Import and Export (K Units)
Figure Europe Temozolomide Production Growth Rate 2014-2019 (K Units)
Figure Europe Temozolomide Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Temozolomide Production, Consumption Import and Export (K Units)
Figure China Temozolomide Production Growth Rate 2014-2019 (K Units)
Figure China Temozolomide Revenue Growth Rate 2014-2019 (Million USD)
Table China Temozolomide Production, Consumption Import and Export (K Units)
Figure Japan Temozolomide Production Growth Rate 2014-2019 (K Units)
Figure Japan Temozolomide Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Temozolomide Production, Consumption Import and Export (K Units)
Figure Southeast Asia Temozolomide Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Temozolomide Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Temozolomide Production, Consumption Import and Export (K Units)
Figure India Temozolomide Production Growth Rate 2014-2019 (K Units)
Figure India Temozolomide Revenue Growth Rate 2014-2019 (Million USD)
Table India Temozolomide Production, Consumption Import and Export (K Units)
Figure Global Consumption Temozolomide Market Share by Application (2014-2019)
Figure Global Value (Consumption) Temozolomide Market Share by Application (2014-2019)
Table Merck Temozolomide Production Sites and Area Served
Table Merck Temozolomide Product Introduction, Application and Specification
Table Merck Temozolomide Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Temozolomide Production Growth Rate (2014-2019)
Table Merck Temozolomide Production Market Share (2014-2019)
Figure Merck Temozolomide Revenue Market Share (2014-2019)
Table Merck Temozolomide Main Business and Markets Served
Table SL Pharme Temozolomide Production Sites and Area Served
Table SL Pharme Temozolomide Product Introduction, Application and Specification
Table SL Pharme Temozolomide Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table SL Pharme Temozolomide Production Growth Rate (2014-2019)
Table SL Pharme Temozolomide Production Market Share (2014-2019)
Figure SL Pharme Temozolomide Revenue Market Share (2014-2019)
Table SL Pharme Temozolomide Main Business and Markets Served
Table Sun Pharma Temozolomide Production Sites and Area Served
Table Sun Pharma Temozolomide Product Introduction, Application and Specification
Table Sun Pharma Temozolomide Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Sun Pharma Temozolomide Production Growth Rate (2014-2019)
Table Sun Pharma Temozolomide Production Market Share (2014-2019)
Figure Sun Pharma Temozolomide Revenue Market Share (2014-2019)
Table Sun Pharma Temozolomide Main Business and Markets Served
Table Mayne Pharma Temozolomide Production Sites and Area Served
Table Mayne Pharma Temozolomide Product Introduction, Application and Specification
Table Mayne Pharma Temozolomide Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Mayne Pharma Temozolomide Production Growth Rate (2014-2019)
Table Mayne Pharma Temozolomide Production Market Share (2014-2019)
Figure Mayne Pharma Temozolomide Revenue Market Share (2014-2019)
Table Mayne Pharma Temozolomide Main Business and Markets Served
Table Schering-Plough Temozolomide Production Sites and Area Served
Table Schering-Plough Temozolomide Product Introduction, Application and Specification
Table Schering-Plough Temozolomide Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Schering-Plough Temozolomide Production Growth Rate (2014-2019)
Table Schering-Plough Temozolomide Production Market Share (2014-2019)
Figure Schering-Plough Temozolomide Revenue Market Share (2014-2019)
Table Schering-Plough Temozolomide Main Business and Markets Served
Table Cipla Temozolomide Production Sites and Area Served
Table Cipla Temozolomide Product Introduction, Application and Specification
Table Cipla Temozolomide Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Cipla Temozolomide Production Growth Rate (2014-2019)
Table Cipla Temozolomide Production Market Share (2014-2019)
Figure Cipla Temozolomide Revenue Market Share (2014-2019)
Table Cipla Temozolomide Main Business and Markets Served
Figure Global Temozolomide Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Temozolomide Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Temozolomide Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Temozolomide Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Temozolomide Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Temozolomide Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Temozolomide Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Temozolomide Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Temozolomide Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Temozolomide Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Temozolomide Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Temozolomide Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Temozolomide Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Temozolomide Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Temozolomide Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Temozolomide by Type (2019-2025)
Table Global Consumption (K Units) of Temozolomide by Application (2019-2025)
Table Temozolomide Distributors List
Table Temozolomide Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Merck、SL Pharme、Sun Pharma、Mayne Pharma、Schering-Plough、Cipla、

★調査レポート[世界のテモゾロミド市場 2019年] (コード:DATA909X16318)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のテモゾロミド市場 2019年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆